Filing Details

Accession Number:
0001127602-13-026324
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-30 16:58:09
Reporting Period:
2013-08-28
Filing Date:
2013-08-30
Accepted Time:
2013-08-30 16:58:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1014739 Bioscrip Inc. BIOS Retail-Drug Stores And Proprietary Stores (5912) 050489664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193140 R David Hubers 100 Clearbrook Road
Elmsford NY 10523
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Disposition 2013-08-28 26,600 $0.00 0 No 4 J Indirect David R. Hubers 2010 GRAT No. 1 U/A/D 07/29/2010
Common Stock, $.0001 Par Value Acquisiton 2013-08-28 26,600 $0.00 42,362 No 4 J Indirect By The David R. Hubers Revocable Trust
Common Stock, $.0001 Par Value Acquisiton 2013-08-28 11,200 $7.97 82,560 No 4 M Direct
Common Stock, $.0001 Par Value Disposition 2013-08-28 11,200 $12.23 71,360 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect David R. Hubers 2010 GRAT No. 1 U/A/D 07/29/2010
No 4 J Indirect By The David R. Hubers Revocable Trust
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.0001 Par Value Director Stock Option Disposition 2013-08-28 11,200 $0.00 11,200 $7.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-11-19 No 4 M Direct
Footnotes
  1. Distribution by grantor retained annuity trust in satisfaction of annuity obligation.
  2. Mr. Hubers' spouse is the trustee of the trust. Mr. Hubers' daughters are remaindermen of the trust.
  3. The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions in prices ranging from $12.20 to $12.31, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. Fully Vested